772 related articles for article (PubMed ID: 26086864)
21. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock.
Cavender MA; Rajeswaran J; DiPaola L; Houghtaling P; Kiernan MS; Rassi AN; Menon V; Whitlow PW; Ellis SG; Shishehbor MH
J Invasive Cardiol; 2013 May; 25(5):218-24. PubMed ID: 23645045
[TBL] [Abstract][Full Text] [Related]
23. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
[TBL] [Abstract][Full Text] [Related]
24. In-Stent Dissection Causes No Flow During Percutaneous Coronary Intervention.
Yashima F; Yuasa S; Maekawa Y; Kimura M; Akita K; Yanagisawa R; Tanaka M; Hayashida K; Kawakami T; Kanazawa H; Fujita J; Fukuda K
JACC Cardiovasc Interv; 2016 Jan; 9(1):102-103. PubMed ID: 26685075
[No Abstract] [Full Text] [Related]
25. Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial.
Wu X; Maehara A; He Y; Xu K; Oviedo C; Witzenbichler B; Lansky AJ; Dressler O; Parise H; Stone GW; Mintz GS
Catheter Cardiovasc Interv; 2013 Aug; 82(2):203-9. PubMed ID: 22936619
[TBL] [Abstract][Full Text] [Related]
26. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
27. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
[TBL] [Abstract][Full Text] [Related]
28. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI.
Saia F; Komukai K; Capodanno D; Sirbu V; Musumeci G; Boccuzzi G; Tarantini G; Fineschi M; Tumminello G; Bernelli C; Niccoli G; Coccato M; Bordoni B; Bezerra H; Biondi-Zoccai G; Virmani R; Guagliumi G;
JACC Cardiovasc Imaging; 2015 May; 8(5):566-575. PubMed ID: 25890582
[TBL] [Abstract][Full Text] [Related]
29. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
[TBL] [Abstract][Full Text] [Related]
30. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
[TBL] [Abstract][Full Text] [Related]
32. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
[TBL] [Abstract][Full Text] [Related]
33. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
[TBL] [Abstract][Full Text] [Related]
34. Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.
Tang J; Chu J; Hou H; Lai Y; Tu S; Chen F; Yao Y; Ye Z; Gao Y; Mao Y; Zhuang S; Liu X
Int J Cardiovasc Imaging; 2021 Mar; 37(3):755-766. PubMed ID: 33044717
[TBL] [Abstract][Full Text] [Related]
35. Matrix Metalloproteinase-9 in the Culprit Coronary Artery and Myocardial No-Reflow.
Dong M; Mu N; Ren F; Li F; Zhang C; Yang J
Am J Med Sci; 2015 Nov; 350(5):352-6. PubMed ID: 26359995
[TBL] [Abstract][Full Text] [Related]
36. Predictive performance of dual modality of computed tomography angiography and intravascular ultrasound for no-reflow phenomenon after percutaneous coronary stenting in stable coronary artery disease.
Okutsu M; Horio T; Tanaka H; Akiyama M; Okimoto N; Tsubouchi T; Kawajiri K; Ohashi Y; Sumitsuji S; Ikari Y
Heart Vessels; 2018 Oct; 33(10):1121-1128. PubMed ID: 29644449
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Ikenaga H; Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Miura F; Nakama Y; Dai K; Ohtani T; Ohi K; Miki T; Nakamura M; Kishimoto S; Sumimoto Y; Kihara Y
J Cardiol; 2013 Aug; 62(2):71-6. PubMed ID: 23680004
[TBL] [Abstract][Full Text] [Related]
38. Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel disease.
Loh JP; Kitabata H; Torguson R; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Cardiovasc Revasc Med; 2013; 14(5):258-63. PubMed ID: 24034862
[TBL] [Abstract][Full Text] [Related]
39. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience.
Khattab AA; Abdel-Wahab M; Röther C; Liska B; Toelg R; Kassner G; Geist V; Richardt G
Clin Res Cardiol; 2008 Jan; 97(1):32-8. PubMed ID: 17694377
[TBL] [Abstract][Full Text] [Related]
40. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
